Navigation Links
UT Southwestern researcher awarded Gates Foundation grant for novel vaccine development
Date:10/22/2008

DALLAS Oct. 22, 2008 The Bill and Melinda Gates Foundation announced today that it has awarded a UT Southwestern Medical Center scientist a grant to pursue innovative vaccine research.

The $100,000 grant to Dr. Ellen Vitetta, director of the Cancer Immunobiology Center at UT Southwestern, is one of 104 grants awarded in the first funding round of the Grand Challenges Explorations program, a $100 million, five-year initiative to promote innovation in global health. Additional funding of $1 million or more will be available for projects that show promise, according to the Gates Foundation.

Dr. Vitetta's work will focus on a new approach to developing "mimetic vaccines," which would be based on using synthetic molecules called peptoids to generate a protective immune response to a given pathogen. Dr. Thomas Kodadek, professor of internal medicine and an expert in peptoid chemistry, is a collaborator on the project.

Currently, vaccines are developed using dead or attenuated microbes, or bits and pieces of the infectious agent itself, as a basis for stimulating the human immune system to produce antibodies, or infection-fighting agents, against the disease. Dr. Vitetta's research group will screen thousands of peptoids for their ability to bind to pre-made monoclonal antibodies that are already known to neutralize all varieties of a given pathogen. For example, the researchers will look for peptoids that bind to antibodies that recognize structural features shared by all HIV strains.

"The key advantage to using peptoids to develop mimetic vaccines is that these vaccines would not be limited in their effectiveness to a particular strain or subspecies of a given virus, but rather recognize all viruses of each type. Furthermore huge libraries of peptoids can be made and screened," said Dr. Vitetta, who holds the Scheryle Simmons Patigian Distinguished Chair in Cancer Immunobiology.

Once promising peptoids are identified, they will be attached to "carriers" and tested in mice to determine whether they can actually elicit antibodies that neutralize the pathogen. Dr. Vitetta said the challenge and novelty of this approach is to demonstrate that these anti-peptoid antibodies can mimic those the body produces against the actual native pathogen and confer protective immunity.

"This is high-risk, high-impact research, meaning that there is a high risk of failure," Dr. Vitetta said. "But if our experiments are successful, we hope to identify peptoid mimetics that recognize all variants of HIV, and if we are extremely lucky, we will have a useful vaccine for HIV, which will have tremendous impact. Our work could also open the door for vaccines against other pathogens, such as West Nile virus, hepatitis C and influenza. Even if we fail entirely, we will gain a great deal of insight into what we need to do to make mimetic vaccines work."


'/>"/>

Contact: Amanda Siegfried
amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related biology news :

1. RSV may hide in the lungs, lead to asthma, UT Southwestern researchers report
2. Waste from gut bacteria helps host control weight, UT Southwestern researchers report
3. Antidepressants need new nerve cells to be effective, UT Southwestern researchers find
4. Limiting fructose may boost weight loss, UT Southwestern researcher reports
5. UT Southwestern researchers identify new targets for RNAs that regulate genes
6. UT Southwestern researchers create molecule that nudges nerve stem cells to mature
7. Geology and biology meet in the history of US southwestern desert surface waters
8. Mouse model developed at UT Southwestern mimics hyperglycemia, aids in diabetes research
9. Gene mutations in mice mimic human-like sleep disorder, UT Southwestern researchers find
10. UT Southwesterns Mangelsdorf elected to National Academy of Sciences
11. NIH awards $6.5 million grant to UT Southwestern to develop new antibiotic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/22/2017)... , March 21, 2017   Neurotechnology ... object recognition technologies, today announced the release of ... (SDK), which provides improved facial recognition using up ... on a single computer. The new version uses ... improve accuracy, and it utilizes a Graphing Processing ...
Breaking Biology News(10 mins):
(Date:9/19/2017)... ... September 19, 2017 , ... Participants ... and a high-performance fume hood. Along with the advantages and disadvantages of ductless, ... vs. ducted hoods in the laboratory. , Attendees will learn from an industry ...
(Date:9/19/2017)... ... , ... VetStem Biopharma ’s CEO and founder, Dr. Bob Harman DVM, MPVM, is featured ... Cell Therapy: A Rising Tide". Dr. Harman and Dr. Riordan met in 2003 and ... in the potential of stem cell therapy and a fast friendship was formed. , Dr. ...
(Date:9/19/2017)... ... September 19, 2017 , ... One of the biggest ... eliminated, said Lyle Probst, President, CEO and Founder of ExcitePCR ™. ... pathogen detection solutions, Probst said, “Sample preparation takes place inside our FireflyDX systems, ...
(Date:9/19/2017)... Ann Arbor, MI (PRWEB) , ... September 19, ... ... chemical testing laboratory, is pleased to announce the recipients of its 2017 Science ... academic achievement, exceptional leadership qualities, and involvement with community service defray the costs ...
Breaking Biology Technology: